Disease: Wohlwill-Andrade syndrome
- A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- A rare variant in the TTR gene (p.E112K) is associated with systemic amyloidosis and a new symptom - skin hyperemia in response to ethanol intake: family segregation analysis, literature review, and a clinical case. Case report
- Acoramidis in Transthyretin Amyloid Cardiomyopathy
- Acoramidis in Transthyretin Amyloid Cardiomyopathy. Reply
- Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy
- Altered gut microbiota in Taiwanese A97S predominant transthyretin amyloidosis with polyneuropathy
- Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review
- Amyloid Typing in Cardiac Amyloidosis Using Western Blotting
- Amyloïdose héréditaire à transthyrétine accompagnée d’un syndrome du canal carpien
- An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis
- Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model
- Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis
- Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv)
- Cardiac amyloidosis in Latin America: Gaps and opportunities to increase awareness of the disease. Findings from the AMILO-LATAM research group
- Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters
- Cardiac scintigraphy and echocardiography assessment in the diagnosis of transthyretin cardiac amyloidosis
- Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis
- Case of Biopsy-Proven Wild-Type ATTR Cardiac Amyloidosis With Abnormal CMR and Negative <sup>99m</sup>Tc-HDP and PYP Nuclear Scintigraphy
- Cholesterol and Sphingomyelin Uniquely Alter the Rate of Transthyretin Aggregation and Decrease the Toxicity of Amyloid Fibrils
- Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy
- Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease
- Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
- Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis
- Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States
- Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician
- Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy
- Dapagliflozin treatment and cardiovascular outcome in RBP4/TTR<sup>Val30Met</sup> (transthyretin cardiac amyloidosis) mice
- Deep learning approach for automated segmentation of myocardium using bone scintigraphy single-photon emission computed tomography/computed tomography in patients with suspected cardiac amyloidosis
- Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
- Detecting transthyretin amyloid cardiomyopathy (ATTR-CM) using machine learning: an evaluation of the performance of an algorithm in a UK setting
- Detection of TTR Amyloid in the Conjunctiva Using a Novel Fluorescent Ocular Tracer
- Diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States: Recommendations from a panel of experts
- Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy
- Difference in cardiac uptake between <sup>99m</sup>Tc-HMDP and <sup>99m</sup>Tc-DPD for the non-invasive diagnosis of cardiac transthyretin amyloidosis
- Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report
- Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy
- Early detection of nerve involvement in presymptomatic TTR mutation carriers: exploring potential markers of disease onset
- Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver
- Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid-Based Nanoparticles
- Epidemiological study of the subtype frequency of systemic amyloidosis listed in the Annual of the Pathological Autopsy Cases in Japan
- Exercise Intervention for Patients With Transthyretin Amyloid Cardiomyopathy (EXCITE-ATTR-CM) Pilot Study
- Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation
- Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden
- Heart failure secondary to amyloidosis AL: diagnosis and treatment
- Hepatic and cardiac shear wave elastography in the assessment of hereditary transthyretin amyloidosis
- Hereditary transthyretin amyloidosis presenting with carpal tunnel syndrome
- Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy
- Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week
- Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry
- Identification of Structures Labeled by Indocyanine Green in the Rat Choroid and Retina Can Guide Interpretation of Indocyanine Green Angiography
- Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy
- In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo
- Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis
- Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases
- Inhibitors of Transthyretin Amyloidosis: How to Rank Drug Candidates Using X-ray Crystallography Data
- Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation
- Late-onset familial amyloidosis polyneuropathy associated with c.186G>C in transthyretin
- Low-sensitivity 99mTc pyrophosphate scintigraphy for hereditary transthyretin cardiac amyloidosis with Glu112Lys genotype
- Microbial keratitis in lattice corneal dystrophy: microsporidia as a new cause
- Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
- Multimodality imaging of simultaneous occurrence of cardiac transthyretin amyloidosis and cardiac sarcoidosis
- Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
- Musculoskeletal co-morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review
- Nanoparticles and siRNA: A new era in therapeutics?
- Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis
- Novel electrocardiographic criteria may render possible the more accurate recognition of cardiac amyloidosis
- Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study
- Outcomes of Octogenarian Patients Treated with Tafamidis for Transthyretin Amyloid Cardiomyopathy
- Patisiran in Patients with Transthyretin Cardiac Amyloidosis
- Patisiran in Patients with Transthyretin Cardiac Amyloidosis. Reply
- Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis
- Performance of <sup>99m</sup>Tc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis
- Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
- Prevalence of moderate-severe aortic stenosis in patients with cardiac amyloidosis in a referral center
- Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
- Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure
- Rare ATTR wild-type cardiac amyloidosis after kidney transplantation
- Rare c.302C>T <em>TTR</em> Variant Associated with Transthyretin Amyloidosis
- Real-life experience with inotersen at CEPARM, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro
- Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin
- RNA therapeutics for metabolic disorders
- Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis
- Silencing of ocular transthyretin, a gene responsible for hereditary transthyretin amyloidosis, by intravitreal injection of an siRNA conjugate into rabbit eyes
- Simultaneous onset of acute myocardial infarction, bicuspid aortic stenosis, and cardiac transthyretin amyloidosis-A clinically complex confluence
- siRNA therapy improves multimodality imaging in hereditary transthyretin cardiac amyloidosis: a case report
- SPECT/CT SUV-based metrics: A promising diagnostic tool in classifying patients with suspected transthyretin cardiac amyloidosis among the different Perugini grades?
- Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy
- Structures and Dynamics of β-Rich Oligomers of ATTR (105-115) Assembly
- Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study
- Tafamidis in Octogenarians: An ATTR-ACT-ive Choice
- The landscape of nanoparticle-based siRNA delivery and therapeutic development
- Time is a gift: time-dependent uptake of DPD in cardiac amyloidosis
- Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis
- Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysis
- Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019)
- Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?
- Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort
- Use of Technetium-99m-Pyrophosphate Single-Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy
- Wild-type cardiac amyloidosis with a negative bone scintigraphy: A case report
- World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)